ArticleJournal of oncology2019

Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to Inhibit Tumorigenesis in Pancreatic Cancer.

Dongfeng Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.